In 2025, Cellectis will continue to focus its efforts and expenses on advancing its core clinical trials BALLI-01 and NATHALI-01, while building the next generation of genomic medicines to address ...
ONE of the hottest discussions on TikTok right now is whether trans women should be included in the conversations and celebrations for International Women’s Month. One side argues that trans women ...